+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Prenatal Diagnostics: Global Strategic Business Report

  • PDF Icon

    Report

  • 194 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4721432

Global Prenatal Diagnostics Market to Reach $14.2 Billion by 2030

The global market for Prenatal Diagnostics estimated at US$4.7 Billion in the year 2022, is projected to reach a revised size of US$14.2 Billion by 2030, growing at a CAGR of 14.7% over the analysis period 2022-2030. Non-Invasive, one of the segments analyzed in the report, is projected to record 18.3% CAGR and reach US$10.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Invasive segment is readjusted to a revised 7.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 20.8% CAGR

The Prenatal Diagnostics market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 20.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.9% and 12.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.

Select Competitors (Total 43 Featured) -

  • ANGLE Plc
  • Berry Genomics Co. Ltd.
  • BGI Genomics
  • F. Hoffmann-La Roche Ltd.
  • Hologic Inc.
  • Illumina Inc.
  • Laboratory Corporation of America® Holdings
  • Lifecodexx AG
  • Natera Inc.
  • Quest Diagnostics Inc.
  • Ravgen Inc.
  • Sequenom Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Prenatal Testing: An Introductory Prelude
  • Recent Market Activity
  • The Rationale for Prenatal Genetic Testing
  • Steady Growth Projected Over the Coming Years for Prenatal Testing
  • Developed Regions: Primary Revenue Contributors
  • Fast Paced Growth Forecasts in Developing Regions
  • Northbound Trajectory in Healthcare Spending Creates Conducive Environment
  • Prevailing Economic Scenario Favors Increased Healthcare Spending
  • Progressive Momentum in Med Tech Sector Generates Parallel Opportunities
  • Prenatal Diagnostics - Global Key Competitors Percentage Market Share in 2023 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
2. FOCUS ON SELECT PLAYERS
  • ANGLE Plc (UK)
  • Berry Genomics Co., Ltd. (China)
  • BGI Genomics (Denmark)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Hologic, Inc. (USA)
  • Illumina, Inc. (USA)
  • Laboratory Corporation of America® Holdings (USA)
  • Sequenom, Inc. (USA)
  • Lifecodexx AG (Germany)
  • Natera, Inc. (USA)
  • Quest Diagnostics, Inc. (USA)
  • Ravgen, Inc. (USA)
3. MARKET TRENDS & DRIVERS
  • Non-Invasive Prenatal Testing (NIPT) Transforms Prenatal Testing Landscape
  • Major Factors Influencing Penetration of NIPT
  • NIPT Eliminates Risks & Uncertainty of Conventional Procedures
  • Replacing Screening Tests - A More Conceivable Change through NIPT
  • Diversity in NIPT Usage on the Cards
  • Benefits Outweigh Snags in NIPT Tests
  • Whole Genome Sequencing Technology in NIPT
  • DNA - More Ideal Target for NIPT Analysis than Whole Cells
  • Conventional Invasive Techniques Loose Sheen
  • Chromosomal Abnormalities Lead the Prenatal Testing Space
  • Chromosomal Abnormalities - A Substantial Economic Burden
  • List of Genetic Disorders by Event, Genetic Manifestation and Prevalence
  • Significant Opportunities in Down's Syndrome Testing
  • List of Select Screening Tests Available for T21 Screening and Confirmation
  • Beyond Down's Syndrome - Need to Test Additional Targets Crucial
  • Trisomy 18 or Edward's Syndrome
  • Trisomy 13 or Patau Syndrome
  • Cystic Fibrosis Screening and Diagnosis
  • Cystic Fibrosis Screening Market - Highly Fragmented
  • ACOG and ACGM Recommendations Boost Demand for Prenatal CF Testing
  • Prenatal Testing Crucial to Detect Risk of Huntington's Disease
  • Increasing Congenital Disorder Incidence - Key Driver for Prenatal Diagnostics
  • Prenatal Testing - Effective Way of Alleviating Syphilis Related Deaths and Stillbirths
  • Molecular Diagnostics Widen Scope & Span of Prenatal Testing
  • NGS & MPS - Enabling Shorter Time to Test Results
  • Microarray-Based Prenatal Testing Gathers Steam
  • Sequencing in Prenatal Testing - A Potential High Growth Market
  • Ultrasound - An Indispensable Combination with Blood Based Screening Tests
  • New Sub-Targets on the Anvil for Ultrasound-Based Screening
  • Counseling - An Imperative Measure Before and After Prenatal Testing
  • Role of Prenatal Testing in Managing Preterm Births
  • Lower Sensitivity & Specificity of Existing Tests - A Case for New Tests on the Anvil
  • High Sensitivity Serum Tests May Not Have Many Takers
  • Ballooning Global Female Population Offers Increased Growth Opportunities
  • Issues & Challenges
  • Prenatal Diagnostics: Treading Sensitive Ethical Issues
  • Controversy Related to "Incidental Findings" of Prenatal Tests
  • Opposition to NIPT Technique - A Significant Hurdle to Adoption
  • Unresolved Issues Hamper Widespread Testing for Monogenetic Disease
  • Dearth of Genetic Counselors - A Major Hurdle for Genetic Testing
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Prenatal Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Prenatal Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Prenatal Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Non-Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Trisomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Trisomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Trisomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Micro-Deletions Symptoms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Micro-Deletions Symptoms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 15: World 16-Year Perspective for Micro-Deletions Symptoms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 18: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 20: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 21: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 24: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 27: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 28: World Prenatal Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
CANADA
JAPAN
  • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
CHINA
  • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
EUROPE
  • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
FRANCE
  • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
GERMANY
  • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
ITALY
UNITED KINGDOM
  • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
AUSTRALIA
  • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ANGLE Plc
  • Berry Genomics Co. Ltd.
  • BGI Genomics
  • F. Hoffmann-La Roche Ltd.
  • Hologic Inc.
  • Illumina Inc.
  • Laboratory Corporation of America® Holdings
  • Lifecodexx AG
  • Natera Inc.
  • Quest Diagnostics Inc.
  • Ravgen Inc.
  • Sequenom Inc.

Table Information